Business
CSL to Buy Aventis Plasma Business for up to $925 Million
In a transaction that will complement the company's own plasma business, CSL Limited has agreed to acquire Aventis Behring , the therapeutic proteins business of Aventis for an up-front payment of U.S.$550 million plus deferred payments More...12 Dec 2003
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
MR Trolley
MR9002
New
Patient Monitor
IntelliVue MP5SC
In Other News
Alliance to Develop Treatment for Bypass Vein Grafts
Zimmer to Acquire Developer of Trabecular Metal
Angiotech to Acquire STS Biopolymers
Intermagnetics Offers to Buy Invivo for $140 Million
Hologic and Aloka Announce Distribution Agreement
Kodak to Purchase Algotec for $42 Milion
Boston Scientific and Biophan in MRI Collaboration
Alliance to Develop Optical Imaging Products
Thermo Electron Acquires Instrument Validation Firm
UK Firm to Acquire Orchid's Diagnostic Unit
Toshiba Announces PET Distribution Agreement
IsoTis and GenSci Orthobiologics Complete Merger
Baxter Acquires Assets from Maker of Antitrypsin Drug
Varian and Mitsubishi to Form Joint Radiotherapy Venture
Cardiac Science Acquires AED Training Company
Varian Medical Systems to Acquire Zmed
Medical Division May Be Philips' Biggest Profit Unit in 2004
Bayer Acquires Inhalation Technology for AAT Dosing
Zimmer to Distribute Rotator Cuff Patch
R&D Systems to Develop Cytokine Assays for Beckman
Inverness Buys Rapid Tests from Abbott for $92.5 Million
Collaboration to Advance Molecular Imaging Technology
Pharmaceutical Firm Sells Dosimetry Division
HospiMedica Industry News channel updates the reader on mergers and takeovers, on cooperative agreements and on trends in the healthcare industry worldwide.